Date published:
03/19/2018
Cybersecurity breaches in the pharmaceutical industry are now more dangerous than ever. Internet-connected industrial control systems (ICS) are being targeted and malware is being designed to steal valuable intellectual property (IP) and hold it for ransom. With pharmaceutical companies being labeled as a primary target for cybercriminals, the time is now for these organizations to assess the effectiveness of their cybersecurity program.
Author: